Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nemucore Medical Innovations

Nemucore Medical Innovations?uq=AFYHfsyn
2008 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$225K LATEST DEAL AMOUNT
3 INVESTORS
Description

Operator of a clinical development company intended to offer molecularly-targeted nanomedicines. The company's clinical development services include development and commercialization of NMI-900 a life-saving molecularly-targeted therapeutic which is a aurora B Kinase inhibitor that evades cancer defenses and delivers medications that can treat tumors, enabling cancer patients to treat newly diagnosed, recurrent and multi-drug resistant cancers.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Drug Delivery
Primary Office
  • One Hollis Street
  • Suite 232
  • Wellesley, MA 02482
  • United States

+1 (508) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nemucore Medical Innovations’s full profile, request a free trial.

Nemucore Medical Innovations Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 31-Jan-2016 $225K 000 Completed Generating Revenue
6. Angel (individual) 07-Dec-2015 000 000 000.00 Completed Generating Revenue
5. Grant 31-Jul-2015 00000 Completed Generating Revenue
4. Grant 01-Jan-2013 00000 Completed Generating Revenue
3. Grant 31-Aug-2012 00000 Completed Generating Revenue
2. Accelerator/Incubator 10-Apr-2012 Completed Generating Revenue
1. Grant 01-Jan-2010 $302K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Nemucore Medical Innovations Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00 00 00 0.000
To view this company’s complete Cap Table, request access »

Nemucore Medical Innovations Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Boynton Angels Angel Group Minority 000 0000 000000 0
Massachusetts Biomedical Initiatives Accelerator/Incubator 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Nemucore Medical Innovations Executive Team (5)

Name Title Board
Seat
Contact
Info
Timothy Coleman Ph.D Co-Founder, Chief Executive Officer, President & Chairman of the Board
William White Chief Operating Officer, Chief Business Officer & Board Member
Barbara Davis Ph.D Chief Scientific Officer & Vice President of Toxicology and Pathology
Daniel Geffken Chief Financial Officer

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Nemucore Medical Innovations Board Members (8)

Name Representing Role Since Contact
Info
Bryan Costantino Self Board Member and Audit Chairman 000 0000
Doug Bailey Nemucore Medical Innovations Board Member & Chairman of the Compensation Committee 000 0000
James Farinholt Jr. Self Board Member & Chairman of the Nomination and Governance Committee 000 0000
Michael Seiden Nemucore Medical Innovations Board Member & Scientific Advisor 000 0000
Timothy Coleman Ph.D Nemucore Medical Innovations Co-Founder, Chief Executive Officer, President & Chairman of the Board 000 0000

2 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »